Müller H, Betz LT, Kambeitz J, Falkai P, Gaebel W, Heinz A, Hellmich M, Juckel G, Lambert M, Meyer-Lindenberg A, Schneider F, Wagner M, Zink M, Klosterkötter J, Bechdolf A. Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis. Schizophrenia (Heidelb). 2022 8(1):68.
Praus P, Schwarz S, Reinhard I, Zink M, Dreßing H. [Validity of the "Structured Inventory of Malingered Symptomatology" [SIMS] in the Assessment of Healthy Individuals and Patients with Psychiatric Disorders Outside the Forensic Context]. Fortschr Neurol Psychiatr. 2022 90(3):100-107. Epub 2021 Jun 11.
Schirmbeck F, Zink M. [Obsessive-compulsive symptoms in psychotic disorders: pathogenesis and treatment]. Nervenarzt. 2022 93(7):688-694.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Verde PE, Correll CU, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl TB, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Cordes J, COMBINE Study Group . Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial. Lancet Psychiatry. 2022 9(4):291-306.